244 related articles for article (PubMed ID: 8674049)
1. Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide.
Watanabe H; Takehana K; Date M; Shinozaki T; Raz A
Cancer Res; 1996 Jul; 56(13):2960-3. PubMed ID: 8674049
[TBL] [Abstract][Full Text] [Related]
2. Expression and secretion of neuroleukin/phosphohexose isomerase/maturation factor as autocrine motility factor by tumor cells.
Niinaka Y; Paku S; Haga A; Watanabe H; Raz A
Cancer Res; 1998 Jun; 58(12):2667-74. PubMed ID: 9635595
[TBL] [Abstract][Full Text] [Related]
3. Crystal structures of mouse autocrine motility factor in complex with carbohydrate phosphate inhibitors provide insight into structure-activity relationship of the inhibitors.
Tanaka N; Haga A; Naba N; Shiraiwa K; Kusakabe Y; Hashimoto K; Funasaka T; Nagase H; Raz A; Nakamura KT
J Mol Biol; 2006 Feb; 356(2):312-24. PubMed ID: 16375918
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells.
Funasaka T; Hu H; Yanagawa T; Hogan V; Raz A
Cancer Res; 2007 May; 67(9):4236-43. PubMed ID: 17483335
[TBL] [Abstract][Full Text] [Related]
5. Inhibition mechanism of cytokine activity of human autocrine motility factor examined by crystal structure analyses and site-directed mutagenesis studies.
Tanaka N; Haga A; Uemura H; Akiyama H; Funasaka T; Nagase H; Raz A; Nakamura KT
J Mol Biol; 2002 May; 318(4):985-97. PubMed ID: 12054796
[TBL] [Abstract][Full Text] [Related]
6. Differential expression and pathological significance of autocrine motility factor/glucose-6-phosphate isomerase expression in human lung carcinomas.
Dobashi Y; Watanabe H; Sato Y; Hirashima S; Yanagawa T; Matsubara H; Ooi A
J Pathol; 2006 Dec; 210(4):431-40. PubMed ID: 17029220
[TBL] [Abstract][Full Text] [Related]
7. Expression of autocrine motility factor/phosphohexose isomerase in Cos7 cells.
Lagana A; Duchaine T; Raz A; DesGroseillers L; Nabi IR
Biochem Biophys Res Commun; 2000 Jun; 273(1):213-8. PubMed ID: 10873589
[TBL] [Abstract][Full Text] [Related]
8. Purification of B16-F1 melanoma autocrine motility factor and its receptor.
Silletti S; Watanabe H; Hogan V; Nabi IR; Raz A
Cancer Res; 1991 Jul; 51(13):3507-11. PubMed ID: 1647268
[TBL] [Abstract][Full Text] [Related]
9. The neurotrophic factor neuroleukin is 90% homologous with phosphohexose isomerase.
Chaput M; Claes V; Portetelle D; Cludts I; Cravador A; Burny A; Gras H; Tartar A
Nature; 1988 Mar; 332(6163):454-5. PubMed ID: 3352744
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts.
Tsutsumi S; Hogan V; Nabi IR; Raz A
Cancer Res; 2003 Jan; 63(1):242-9. PubMed ID: 12517804
[TBL] [Abstract][Full Text] [Related]
11. Heregulin regulation of autocrine motility factor expression in human tumor cells.
Talukder AH; Adam L; Raz A; Kumar R
Cancer Res; 2000 Jan; 60(2):474-80. PubMed ID: 10667603
[TBL] [Abstract][Full Text] [Related]
12. Autocrine motility factor/glucose-6-phosphate isomerase is a possible predictor of metastasis in bone and soft tissue tumours.
Dobashi Y; Watanabe H; Matsubara M; Yanagawa T; Raz A; Shimamiya T; Ooi A
J Pathol; 2006 Jan; 208(1):44-53. PubMed ID: 16294294
[TBL] [Abstract][Full Text] [Related]
13. pH-specific sequestration of phosphoglucose isomerase/autocrine motility factor by fibronectin and heparan sulphate.
Lagana A; Goetz JG; Y N; Altschuler Y; Nabi IR
J Cell Sci; 2005 Sep; 118(Pt 18):4175-85. PubMed ID: 16141236
[TBL] [Abstract][Full Text] [Related]
14. Expression patterns in mouse embryos of neuroleukin/glucose-6-phosphate isomerase and autocrine motility factor receptor.
Repiso A; Andrés R; Climent F; Ureña JM
Anat Histol Embryol; 2008 Oct; 37(5):380-2. PubMed ID: 18537943
[TBL] [Abstract][Full Text] [Related]
15. Phosphohexose isomerase/autocrine motility factor/neuroleukin/maturation factor is a multifunctional phosphoprotein.
Haga A; Niinaka Y; Raz A
Biochim Biophys Acta; 2000 Jul; 1480(1-2):235-44. PubMed ID: 11004567
[TBL] [Abstract][Full Text] [Related]
16. Regulation of phosphoglucose isomerase/autocrine motility factor activities by the poly(ADP-ribose) polymerase family-14.
Yanagawa T; Funasaka T; Tsutsumi S; Hu H; Watanabe H; Raz A
Cancer Res; 2007 Sep; 67(18):8682-9. PubMed ID: 17875708
[TBL] [Abstract][Full Text] [Related]
17. Autocrine motility factor signals integrin-mediated metastatic melanoma cell adhesion and invasion.
Timar J; Trikha M; Szekeres K; Bazaz R; Tovari J; Silletti S; Raz A; Honn KV
Cancer Res; 1996 Apr; 56(8):1902-8. PubMed ID: 8620512
[TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of phosphohexose isomerase from human gastrointestinal carcinoma and its potential relationship to neuroleukin.
Baumann M; Brand K
Cancer Res; 1988 Dec; 48(24 Pt 1):7018-21. PubMed ID: 3191476
[TBL] [Abstract][Full Text] [Related]
19. Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of beta1 integrins.
Torimura T; Ueno T; Kin M; Harada R; Nakamura T; Kawaguchi T; Harada M; Kumashiro R; Watanabe H; Avraham R; Sata M
Hepatology; 2001 Jul; 34(1):62-71. PubMed ID: 11431735
[TBL] [Abstract][Full Text] [Related]
20. Mouse glucose-6-phosphate isomerase and neuroleukin have identical 3' sequences.
Faik P; Walker JI; Redmill AA; Morgan MJ
Nature; 1988 Mar; 332(6163):455-7. PubMed ID: 3352745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
